Company / SG&A per Share
Immuneering Corp SG&A per Share History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.59
FY2023
5-year range
$0.59 / $0.63
FY2021-FY2023
Trend
-2.7%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share remained relatively stable over the past 3 years, with values between $0.59 and $0.63.
Based on SEC 10-K filings.
0.59 in FY2023.
Improved from $0.63 to $0.59 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, sg&a per share decreased 2.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $0.59 | -2.7% |
| FY2022 | $0.61 | -3.3% |
| FY2021 | $0.63 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026